Kaitlyn McGill

Associate
New York
Tel: +1 212 909 6817
Overview
Kaitlyn E. McGill is an associate in the Litigation Department. Ms. McGill joined Debevoise in 2023. Ms. McGill received her J.D. magna cum laude from ... Read Full Biography

Publications

  • California Judge Allows Public Nuisance Claims Against Social Media Companies
    22 November 2024
    Lindsay Cooper Hayman
    ,
    Maura Kathleen Monaghan
    ,
    John (Jay) Neukom
    ,
    Abraham Tabaie
    ,
    Barbara N. Barath
    ,
    Carter Burwell
    ,
    Jacob W. Stahl
    ,
    Kaitlyn McGill
    ,
    Allison Miller
  • 2024 Private Equity Midyear Outlook
    August 2024
    Christopher Anthony
    ,
    Katherine Ashton
    ,
    Dominic Blaxill
    ,
    Ezra Borut
    ,
    Geoffrey P. Burgess
    ,
    Andrew J. Ceresney
    ,
    Christopher Dortschy
    ,
    Jane Engelhardt
    ,
    Andrew Ford
    ,
    Andrew J. Gershon
    ,
    Mark P. Goodman
    ,
    Jyotin Hamid
    ,
    Morgan J. Hayes
    ,
    Peter J. Irwin
    ,
    Eric T. Juergens
    ,
    Arian M. June
    ,
    Robert B. Kaplan
    ,
    M. Natasha Labovitz
    ,
    Andrew M. Levine
    ,
    Sidney P. Levinson
    ,
    Jonathan F. Lewis
    ,
    Gregory J. Lyons
    ,
    Timothy McIver
    ,
    Frank Mitchell
    ,
    Maura Kathleen Monaghan
    ,
    Edwin Northover
    ,
    Brett M. Novick
    ,
    Sheena Paul
    ,
    Marc Ponchione
    ,
    Ryan T. Rafferty
    ,
    Julie M. Riewe
    ,
    Paul D. Rubin
    ,
    Scott B. Selinger
    ,
    Thomas Smith
    ,
    Kristin A. Snyder
    ,
    Rick Sofield
    ,
    Katherine Durnan Taylor
    ,
    Ramya S. Tiller
    ,
    Jonathan R. Tuttle
    ,
    Patricia Volhard
    ,
    Erica S. Weisgerber
    ,
    Jennifer Wheater
    ,
    Naomi Aoyama
    ,
    Alison E. Buckley-Serfass
    ,
    Brett Adam Bush
    ,
    Zhiyan Cao
    ,
    Jennifer R. Cestaro
    ,
    Robert T. Dura
    ,
    Paul Eastham
    ,
    Stuart Hammer
    ,
    Lauren P. Heller
    ,
    Jin-Hyuk Jang
    ,
    Wen-Wei Lai
    ,
    Michael P. McGuigan
    ,
    Melissa Runsten
    ,
    Tricia Bozyk Sherno
    ,
    Jacob W. Stahl
    ,
    John Young
    ,
    Ulysses Smith
    ,
    Kayleigh Anderson
    ,
    Hymie A. Anteby
    ,
    Jabari Benjamin
    ,
    Charles Cartiglia
    ,
    Josephine Chen
    ,
    Jordan Corrente Beck
    ,
    Tejas N. Dave
    ,
    Julia Glazer
    ,
    Michael C. Godbe
    ,
    Zoe Jacoby
    ,
    Yiran Ji
    ,
    Adriana Kranjac
    ,
    Paul D. Lowry
    ,
    Kaitlyn McGill
    ,
    Diana Moise
    ,
    Amy Pereira
    ,
    John M. Satira
    ,
    Eike Björn Weidner
    ,
    Keith Moshe
  • FCPA Update July 2024
    31 July 2024
    Andrew M. Levine
    ,
    Karolos Seeger
    ,
    Alexandre Bisch
    ,
    Nestor D. Almeida
    ,
    Delia M. Arias De Leon
    ,
    Amaya Lefkowitz Driggs
    ,
    Fanny Gauthier
    ,
    Nathan R. Hogan
    ,
    Andrew H. Lee
    ,
    Kaitlyn McGill
    ,
    Lorena Rodriguez
    ,
    Paige Sferrazza
  • Law360: After Chevron: FDA Regulations In The Crosshairs
    8 July 2024
    Law360
    Maura Kathleen Monaghan
    ,
    Paul D. Rubin
    ,
    Jacob W. Stahl
    ,
    Zoe Jacoby
    ,
    Kaitlyn McGill
  • Federal Trade Commission Finalizes Updates to the Health Breach Notification Rule
    20 May 2024
    Andrew L. Bab
    ,
    Avi Gesser
    ,
    Paul D. Rubin
    ,
    Kim T. Le
    ,
    Melissa Runsten
    ,
    Johanna N. Skrzypczyk
    ,
    Hannah R. Levine
    ,
    Kaitlyn McGill
    ,
    Annabella M. Waszkiewicz
  • Increased FCA Enforcement Targeting PE Firms Expected in 2024
    11 March 2024
    Helen V. Cantwell
    ,
    Courtney M. Dankworth
    ,
    Mark P. Goodman
    ,
    Maura Kathleen Monaghan
    ,
    Winston M. Paes
    ,
    Shannon Rose Selden
    ,
    Jacob W. Stahl
    ,
    Adam Aukland-Peck
    ,
    Kaitlyn McGill
  • FCPA Update January 2024
    1 February 2024
    Kara Brockmeyer
    ,
    Andrew J. Ceresney
    ,
    Andrew M. Levine
    ,
    David A. O'Neil
    ,
    Winston M. Paes
    ,
    Karolos Seeger
    ,
    Jane Shvets
    ,
    Bruce E. Yannett
    ,
    Douglas S. Zolkind
    ,
    Alexandre Bisch
    ,
    Erich O. Grosz
    ,
    Emily Lam
    ,
    Dr. Friedrich Popp
    ,
    Philip Rohlik
    ,
    Sarah Wolf
    ,
    Delia M. Arias De Leon
    ,
    Courtney Barger
    ,
    Amaya Lefkowitz Driggs
    ,
    Aisling Cowell
    ,
    Fanny Gauthier
    ,
    Andreas A. Glimenakis
    ,
    Andrew H. Lee
    ,
    Joseph Ptomey
    ,
    Lorena Rodriguez
    ,
    Paige Sferrazza
    ,
    Zhiqi Wu
    ,
    Nestor D. Almeida
    ,
    Kaitlyn McGill
    ,
    Grant Aubrey Simon
    ,
    Raphael Vim
    ,
    Theo Wilson
  • Chevron Under Fire: What Healthcare and Life Sciences Investors Should Know
    19 January 2024
    Andrew L. Bab
    ,
    Jennifer L. Chu
    ,
    Mark P. Goodman
    ,
    Maura Kathleen Monaghan
    ,
    Kevin Rinker
    ,
    Paul D. Rubin
    ,
    Melissa Runsten
    ,
    Jacob W. Stahl
    ,
    Adam Aukland-Peck
    ,
    Zoe Jacoby
    ,
    Adriana Kranjac
    ,
    Kaitlyn McGill
  • Top 10 Healthcare and Life Sciences Issues to Watch in 2024
    4 January 2024
    Andrew L. Bab
    ,
    Jennifer L. Chu
    ,
    Mark P. Goodman
    ,
    Ted Hassi
    ,
    Maura Kathleen Monaghan
    ,
    Kevin Rinker
    ,
    Paul D. Rubin
    ,
    Michael Schaper
    ,
    Erica S. Weisgerber
    ,
    Kim T. Le
    ,
    Melissa Runsten
    ,
    Jacob W. Stahl
    ,
    Adam Aukland-Peck
    ,
    Ilya Balabanovsky
    ,
    Margaret Howard
    ,
    Chaim Lapp
    ,
    Hannah R. Levine
    ,
    Zoe Jacoby
    ,
    Kaitlyn McGill

Upcoming Events

Recent Events